Skip to main content
. 2022 Jan 19;62:1–9. doi: 10.1016/j.breast.2022.01.007

Table 2.

Clinical response and pathological complete response analysis.

CT-P6 (n = 20) RTZ (n = 24) P∗
Clinical complete response 11 (55%; 33.2–76.8) 16 (66.7%; 48.2–85.8) 0.429
Pathological complete response 13 (65%; 44.1–85.9) 16 (66.7%; 48.2–85.8) 0.908

∗p-value from Chi-Square test; p-value under 0.05 is considered as statistical significant.

Data are n (%; 95% CI).